Cambridge, Massachusetts-based Anumana, an AI-driven health technology company, has acquired medical technology company NeuTrace. Terms of the deal were not disclosed.
Headquartered in Longwood, Florida, NeuTrace is a company advancing novel in-procedure AI applications for electrophysiology.
The acquisition includes the NeuTrace EP Data Biome platform and a portfolio of AI-enabled EP software applications in development. As part of the transaction, nference acquired rights to the Data Biome platform for uses outside of the cardiovascular field.
According to the LevinPro HC database, this was the 103rd Medical Devices transaction of 2022. This compares with 106 Medical Devices deals recorded between January 1, 2021, and November 8, 2021.
